Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Oculis Holding AG
Industry Sector: HealthTechnology
CEO: Riad Sherif, MD, MBA
Number Of Employees: 49
Enterprise Value: $579,343,929
PE Ratio: -8.11
Exchange/Ticker 1: NASDAQ:OCS
Exchange/Ticker 2: Iceland:OCS
Latest Market Cap: $943,680,000
BioCentury | Nov 21, 2024
Management Tracks
Boshoff to succeed Dolsten as Pfizer CSO
Plus: Hwang joins Metaphore, Flagship and updates from FDA, MHRA, ArrePath, ABT, Unnatural, Thryv and more
BioCentury | Oct 4, 2024
Management Tracks
Resolution names Paul Sekhri chair
Plus: Dadswell leaving Illumina as general counsel and updates from Eliem, Codexis, Oculis, Illumina, Eupraxia and PharmaJet
BioCentury | Aug 19, 2024
Management Tracks
New commercial, regulatory heads at Fulcrum
Plus: Tiziana names Ivor Elrifi CEO, and updates from Soleno, Latigo, Fog and
BioCentury | Jun 11, 2024
Product Development
Clinical Report: Shionogi mulls next steps after underwhelming obesity readout
Plus: Bluejay, Vir give HDV updates; Skye’s miss in glaucoma; and more
BioCentury | Apr 11, 2024
Management Tracks
Illumina’s Goswami to depart
Plus: Arcutis hires Topper as CFO and Snehal Shah becomes R&D president at
BioCentury | Feb 7, 2024
Management Tracks
Verily names Myoung Cha as chief product officer
Plus: New CFO for Innovent and updates from Takeda, Shionogi, Lexeo, Stuart, Arcellx and more
BioCentury | Sep 11, 2023
Management Tracks
Sanofi alum Sibold named CEO at Madrigal
Plus: Fenimore to succeed Landry as Regeneron CFO and updates from SpringWorks, SalioGen, Oxular, Solu, Flagship, Oculis
Items per page:
1 - 7 of 7